Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-045215

Chief Commercial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wettig Thane Chief Commercial Officer 2023-08-07 Grant or award +200,000 308,261 D
Derivatives
Wettig Thane Chief Commercial Officer 2023-08-07 Grant or award · Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X05/doc4.xml…